 | • レポートコード：QYR2104Z0075 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、91ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥565,500 (USD3,900) | ▷ お問い合わせ |
| Multi User/Five User | ￥848,250 (USD5,850) | ▷ お問い合わせ |
| Enterprise License（同一法人内共有可） | ￥1,131,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査資料では、急性膵炎のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（流体、栄養サポート、根本的問題治療、その他）、用途別市場規模（病院、クリニック、その他）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・急性膵炎の市場動向 ・企業の競争状況、市場シェア ・急性膵炎の種類別市場規模（流体、栄養サポート、根本的問題治療、その他） ・急性膵炎の用途別市場規模（病院、クリニック、その他） ・急性膵炎の北米市場規模2016-2027（アメリカ、カナダ） ・急性膵炎のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・急性膵炎のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・急性膵炎の中南米市場規模2016-2027（メキシコ、ブラジル） ・急性膵炎の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Abbott Laboratories、McNeil Consumer Healthcare、Sun BioPharma、Atox Bio、Calcimedica、D-Pharm Ltd、Dynavax Technologies、Glaxosmithkline） ・結論 |
Acute Pancreatitis. Acute pancreatitis is sudden inflammation of the pancreas that may be mild or life threatening but usually subsides. Gallstones and alcohol abuse are the main causes ofacute pancreatitis.
Market Analysis and Insights: Global Acute Pancreatitis Market
The global Acute Pancreatitis market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Acute Pancreatitis market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Acute Pancreatitis market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Acute Pancreatitis market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Acute Pancreatitis market.
Global Acute Pancreatitis Scope and Market Size
Acute Pancreatitis market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Acute Pancreatitis market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Fluids
Nutritional Support
Treatment of Underlying Issues
Other
Segment by Application
Hospital
Clinic
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Abbott Laboratories
McNeil Consumer Healthcare
Sun BioPharma
Atox Bio
Calcimedica
D-Pharm Ltd
Dynavax Technologies
Glaxosmithkline
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Acute Pancreatitis Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Fluids
1.2.3 Nutritional Support
1.2.4 Treatment of Underlying Issues
1.2.5 Other
1.3 Market by Application
1.3.1 Global Acute Pancreatitis Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Acute Pancreatitis Market Perspective (2016-2027)
2.2 Acute Pancreatitis Growth Trends by Regions
2.2.1 Acute Pancreatitis Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Acute Pancreatitis Historic Market Share by Regions (2016-2021)
2.2.3 Acute Pancreatitis Forecasted Market Size by Regions (2022-2027)
2.3 Acute Pancreatitis Industry Dynamic
2.3.1 Acute Pancreatitis Market Trends
2.3.2 Acute Pancreatitis Market Drivers
2.3.3 Acute Pancreatitis Market Challenges
2.3.4 Acute Pancreatitis Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Acute Pancreatitis Players by Revenue
3.1.1 Global Top Acute Pancreatitis Players by Revenue (2016-2021)
3.1.2 Global Acute Pancreatitis Revenue Market Share by Players (2016-2021)
3.2 Global Acute Pancreatitis Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Acute Pancreatitis Revenue
3.4 Global Acute Pancreatitis Market Concentration Ratio
3.4.1 Global Acute Pancreatitis Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Acute Pancreatitis Revenue in 2020
3.5 Acute Pancreatitis Key Players Head office and Area Served
3.6 Key Players Acute Pancreatitis Product Solution and Service
3.7 Date of Enter into Acute Pancreatitis Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Acute Pancreatitis Breakdown Data by Type
4.1 Global Acute Pancreatitis Historic Market Size by Type (2016-2021)
4.2 Global Acute Pancreatitis Forecasted Market Size by Type (2022-2027)
5 Acute Pancreatitis Breakdown Data by Application
5.1 Global Acute Pancreatitis Historic Market Size by Application (2016-2021)
5.2 Global Acute Pancreatitis Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Acute Pancreatitis Market Size (2016-2027)
6.2 North America Acute Pancreatitis Market Size by Type
6.2.1 North America Acute Pancreatitis Market Size by Type (2016-2021)
6.2.2 North America Acute Pancreatitis Market Size by Type (2022-2027)
6.2.3 North America Acute Pancreatitis Market Size by Type (2016-2027)
6.3 North America Acute Pancreatitis Market Size by Application
6.3.1 North America Acute Pancreatitis Market Size by Application (2016-2021)
6.3.2 North America Acute Pancreatitis Market Size by Application (2022-2027)
6.3.3 North America Acute Pancreatitis Market Size by Application (2016-2027)
6.4 North America Acute Pancreatitis Market Size by Country
6.4.1 North America Acute Pancreatitis Market Size by Country (2016-2021)
6.4.2 North America Acute Pancreatitis Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada
7 Europe
7.1 Europe Acute Pancreatitis Market Size (2016-2027)
7.2 Europe Acute Pancreatitis Market Size by Type
7.2.1 Europe Acute Pancreatitis Market Size by Type (2016-2021)
7.2.2 Europe Acute Pancreatitis Market Size by Type (2022-2027)
7.2.3 Europe Acute Pancreatitis Market Size by Type (2016-2027)
7.3 Europe Acute Pancreatitis Market Size by Application
7.3.1 Europe Acute Pancreatitis Market Size by Application (2016-2021)
7.3.2 Europe Acute Pancreatitis Market Size by Application (2022-2027)
7.3.3 Europe Acute Pancreatitis Market Size by Application (2016-2027)
7.4 Europe Acute Pancreatitis Market Size by Country
7.4.1 Europe Acute Pancreatitis Market Size by Country (2016-2021)
7.4.2 Europe Acute Pancreatitis Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Acute Pancreatitis Market Size (2016-2027)
8.2 Asia-Pacific Acute Pancreatitis Market Size by Type
8.2.1 Asia-Pacific Acute Pancreatitis Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Acute Pancreatitis Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Acute Pancreatitis Market Size by Type (2016-2027)
8.3 Asia-Pacific Acute Pancreatitis Market Size by Application
8.3.1 Asia-Pacific Acute Pancreatitis Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Acute Pancreatitis Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Acute Pancreatitis Market Size by Application (2016-2027)
8.4 Asia-Pacific Acute Pancreatitis Market Size by Region
8.4.1 Asia-Pacific Acute Pancreatitis Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Acute Pancreatitis Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Acute Pancreatitis Market Size (2016-2027)
9.2 Latin America Acute Pancreatitis Market Size by Type
9.2.1 Latin America Acute Pancreatitis Market Size by Type (2016-2021)
9.2.2 Latin America Acute Pancreatitis Market Size by Type (2022-2027)
9.2.3 Latin America Acute Pancreatitis Market Size by Type (2016-2027)
9.3 Latin America Acute Pancreatitis Market Size by Application
9.3.1 Latin America Acute Pancreatitis Market Size by Application (2016-2021)
9.3.2 Latin America Acute Pancreatitis Market Size by Application (2022-2027)
9.3.3 Latin America Acute Pancreatitis Market Size by Application (2016-2027)
9.4 Latin America Acute Pancreatitis Market Size by Country
9.4.1 Latin America Acute Pancreatitis Market Size by Country (2016-2021)
9.4.2 Latin America Acute Pancreatitis Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Acute Pancreatitis Market Size (2016-2027)
10.2 Middle East & Africa Acute Pancreatitis Market Size by Type
10.2.1 Middle East & Africa Acute Pancreatitis Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Acute Pancreatitis Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Acute Pancreatitis Market Size by Type (2016-2027)
10.3 Middle East & Africa Acute Pancreatitis Market Size by Application
10.3.1 Middle East & Africa Acute Pancreatitis Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Acute Pancreatitis Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Acute Pancreatitis Market Size by Application (2016-2027)
10.4 Middle East & Africa Acute Pancreatitis Market Size by Country
10.4.1 Middle East & Africa Acute Pancreatitis Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Acute Pancreatitis Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Abbott Laboratories
11.1.1 Abbott Laboratories Company Details
11.1.2 Abbott Laboratories Business Overview
11.1.3 Abbott Laboratories Acute Pancreatitis Introduction
11.1.4 Abbott Laboratories Revenue in Acute Pancreatitis Business (2016-2021)
11.1.5 Abbott Laboratories Recent Development
11.2 McNeil Consumer Healthcare
11.2.1 McNeil Consumer Healthcare Company Details
11.2.2 McNeil Consumer Healthcare Business Overview
11.2.3 McNeil Consumer Healthcare Acute Pancreatitis Introduction
11.2.4 McNeil Consumer Healthcare Revenue in Acute Pancreatitis Business (2016-2021)
11.2.5 McNeil Consumer Healthcare Recent Development
11.3 Sun BioPharma
11.3.1 Sun BioPharma Company Details
11.3.2 Sun BioPharma Business Overview
11.3.3 Sun BioPharma Acute Pancreatitis Introduction
11.3.4 Sun BioPharma Revenue in Acute Pancreatitis Business (2016-2021)
11.3.5 Sun BioPharma Recent Development
11.4 Atox Bio
11.4.1 Atox Bio Company Details
11.4.2 Atox Bio Business Overview
11.4.3 Atox Bio Acute Pancreatitis Introduction
11.4.4 Atox Bio Revenue in Acute Pancreatitis Business (2016-2021)
11.4.5 Atox Bio Recent Development
11.5 Calcimedica
11.5.1 Calcimedica Company Details
11.5.2 Calcimedica Business Overview
11.5.3 Calcimedica Acute Pancreatitis Introduction
11.5.4 Calcimedica Revenue in Acute Pancreatitis Business (2016-2021)
11.5.5 Calcimedica Recent Development
11.6 D-Pharm Ltd
11.6.1 D-Pharm Ltd Company Details
11.6.2 D-Pharm Ltd Business Overview
11.6.3 D-Pharm Ltd Acute Pancreatitis Introduction
11.6.4 D-Pharm Ltd Revenue in Acute Pancreatitis Business (2016-2021)
11.6.5 D-Pharm Ltd Recent Development
11.7 Dynavax Technologies
11.7.1 Dynavax Technologies Company Details
11.7.2 Dynavax Technologies Business Overview
11.7.3 Dynavax Technologies Acute Pancreatitis Introduction
11.7.4 Dynavax Technologies Revenue in Acute Pancreatitis Business (2016-2021)
11.7.5 Dynavax Technologies Recent Development
11.8 Glaxosmithkline
11.8.1 Glaxosmithkline Company Details
11.8.2 Glaxosmithkline Business Overview
11.8.3 Glaxosmithkline Acute Pancreatitis Introduction
11.8.4 Glaxosmithkline Revenue in Acute Pancreatitis Business (2016-2021)
11.8.5 Glaxosmithkline Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Acute Pancreatitis Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Fluids
Table 3. Key Players of Nutritional Support
Table 4. Key Players of Treatment of Underlying Issues
Table 5. Key Players of Other
Table 6. Global Acute Pancreatitis Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Acute Pancreatitis Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Acute Pancreatitis Market Size by Regions (2016-2021) & (US$ Million)
Table 9. Global Acute Pancreatitis Market Share by Regions (2016-2021)
Table 10. Global Acute Pancreatitis Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 11. Global Acute Pancreatitis Market Share by Regions (2022-2027)
Table 12. Acute Pancreatitis Market Trends
Table 13. Acute Pancreatitis Market Drivers
Table 14. Acute Pancreatitis Market Challenges
Table 15. Acute Pancreatitis Market Restraints
Table 16. Global Acute Pancreatitis Revenue by Players (2016-2021) & (US$ Million)
Table 17. Global Acute Pancreatitis Market Share by Players (2016-2021)
Table 18. Global Top Acute Pancreatitis Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Acute Pancreatitis as of 2020)
Table 19. Ranking of Global Top Acute Pancreatitis Companies by Revenue (US$ Million) in 2020
Table 20. Global 5 Largest Players Market Share by Acute Pancreatitis Revenue (CR5 and HHI) & (2016-2021)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Acute Pancreatitis Product Solution and Service
Table 23. Date of Enter into Acute Pancreatitis Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Acute Pancreatitis Market Size by Type (2016-2021) (US$ Million)
Table 26. Global Acute Pancreatitis Revenue Market Share by Type (2016-2021)
Table 27. Global Acute Pancreatitis Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 28. Global Acute Pancreatitis Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 29. Global Acute Pancreatitis Market Size Share by Application (2016-2021) & (US$ Million)
Table 30. Global Acute Pancreatitis Revenue Market Share by Application (2016-2021)
Table 31. Global Acute Pancreatitis Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 32. Global Acute Pancreatitis Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 33. North America Acute Pancreatitis Market Size by Type (2016-2021) (US$ Million)
Table 34. North America Acute Pancreatitis Market Size by Type (2022-2027) & (US$ Million)
Table 35. North America Acute Pancreatitis Market Size by Application (2016-2021) (US$ Million)
Table 36. North America Acute Pancreatitis Market Size by Application (2022-2027) & (US$ Million)
Table 37. North America Acute Pancreatitis Market Size by Country (2016-2021) & (US$ Million)
Table 38. North America Acute Pancreatitis Market Size by Country (2022-2027) & (US$ Million)
Table 39. Europe Acute Pancreatitis Market Size by Type (2016-2021) (US$ Million)
Table 40. Europe Acute Pancreatitis Market Size by Type (2022-2027) & (US$ Million)
Table 41. Europe Acute Pancreatitis Market Size by Application (2016-2021) (US$ Million)
Table 42. Europe Acute Pancreatitis Market Size by Application (2022-2027) & (US$ Million)
Table 43. Europe Acute Pancreatitis Market Size by Country (2016-2021) & (US$ Million)
Table 44. Europe Acute Pancreatitis Market Size by Country (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Acute Pancreatitis Market Size by Type (2016-2021) (US$ Million)
Table 46. Asia-Pacific Acute Pancreatitis Market Size by Type (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Acute Pancreatitis Market Size by Application (2016-2021) (US$ Million)
Table 48. Asia-Pacific Acute Pancreatitis Market Size by Application (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Acute Pancreatitis Market Size by Region (2016-2021) & (US$ Million)
Table 50. Asia-Pacific Acute Pancreatitis Market Size by Region (2022-2027) & (US$ Million)
Table 51. Latin America Acute Pancreatitis Market Size by Type (2016-2021) (US$ Million)
Table 52. Latin America Acute Pancreatitis Market Size by Type (2022-2027) & (US$ Million)
Table 53. Latin America Acute Pancreatitis Market Size by Application (2016-2021) (US$ Million)
Table 54. Latin America Acute Pancreatitis Market Size by Application (2022-2027) & (US$ Million)
Table 55. Latin America Acute Pancreatitis Market Size by Country (2016-2021) & (US$ Million)
Table 56. Latin America Acute Pancreatitis Market Size by Country (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Acute Pancreatitis Market Size by Type (2016-2021) (US$ Million)
Table 58. Middle East & Africa Acute Pancreatitis Market Size by Type (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Acute Pancreatitis Market Size by Application (2016-2021) (US$ Million)
Table 60. Middle East & Africa Acute Pancreatitis Market Size by Application (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Acute Pancreatitis Market Size by Country (2016-2021) & (US$ Million)
Table 62. Middle East & Africa Acute Pancreatitis Market Size by Country (2022-2027) & (US$ Million)
Table 63. Abbott Laboratories Company Details
Table 64. Abbott Laboratories Business Overview
Table 65. Abbott Laboratories Acute Pancreatitis Product
Table 66. Abbott Laboratories Revenue in Acute Pancreatitis Business (2016-2021) & (US$ Million)
Table 67. Abbott Laboratories Recent Development
Table 68. McNeil Consumer Healthcare Company Details
Table 69. McNeil Consumer Healthcare Business Overview
Table 70. McNeil Consumer Healthcare Acute Pancreatitis Product
Table 71. McNeil Consumer Healthcare Revenue in Acute Pancreatitis Business (2016-2021) & (US$ Million)
Table 72. McNeil Consumer Healthcare Recent Development
Table 73. Sun BioPharma Company Details
Table 74. Sun BioPharma Business Overview
Table 75. Sun BioPharma Acute Pancreatitis Product
Table 76. Sun BioPharma Revenue in Acute Pancreatitis Business (2016-2021) & (US$ Million)
Table 77. Sun BioPharma Recent Development
Table 78. Atox Bio Company Details
Table 79. Atox Bio Business Overview
Table 80. Atox Bio Acute Pancreatitis Product
Table 81. Atox Bio Revenue in Acute Pancreatitis Business (2016-2021) & (US$ Million)
Table 82. Atox Bio Recent Development
Table 83. Calcimedica Company Details
Table 84. Calcimedica Business Overview
Table 85. Calcimedica Acute Pancreatitis Product
Table 86. Calcimedica Revenue in Acute Pancreatitis Business (2016-2021) & (US$ Million)
Table 87. Calcimedica Recent Development
Table 88. D-Pharm Ltd Company Details
Table 89. D-Pharm Ltd Business Overview
Table 90. D-Pharm Ltd Acute Pancreatitis Product
Table 91. D-Pharm Ltd Revenue in Acute Pancreatitis Business (2016-2021) & (US$ Million)
Table 92. D-Pharm Ltd Recent Development
Table 93. Dynavax Technologies Company Details
Table 94. Dynavax Technologies Business Overview
Table 95. Dynavax Technologies Acute Pancreatitis Product
Table 96. Dynavax Technologies Revenue in Acute Pancreatitis Business (2016-2021) & (US$ Million)
Table 97. Dynavax Technologies Recent Development
Table 98. Glaxosmithkline Company Details
Table 99. Glaxosmithkline Business Overview
Table 100. Glaxosmithkline Revenue in Acute Pancreatitis Business (2016-2021) & (US$ Million)
Table 101. Glaxosmithkline Recent Development
Table 102. Research Programs/Design for This Report
Table 103. Key Data Information from Secondary Sources
Table 104. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Acute Pancreatitis Market Share by Type: 2020 VS 2027
Figure 2. Fluids Features
Figure 3. Nutritional Support Features
Figure 4. Treatment of Underlying Issues Features
Figure 5. Other Features
Figure 6. Global Acute Pancreatitis Market Share by Application: 2020 VS 2027
Figure 7. Hospital Case Studies
Figure 8. Clinic Case Studies
Figure 9. Others Case Studies
Figure 10. Acute Pancreatitis Report Years Considered
Figure 11. Global Acute Pancreatitis Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 12. Global Acute Pancreatitis Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Acute Pancreatitis Market Share by Regions: 2020 VS 2027
Figure 14. Global Acute Pancreatitis Market Share by Regions (2022-2027)
Figure 15. Global Acute Pancreatitis Market Share by Players in 2020
Figure 16. Global Top Acute Pancreatitis Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Acute Pancreatitis as of 2020
Figure 17. The Top 10 and 5 Players Market Share by Acute Pancreatitis Revenue in 2020
Figure 18. Global Acute Pancreatitis Revenue Market Share by Type (2016-2021)
Figure 19. Global Acute Pancreatitis Revenue Market Share by Type (2022-2027)
Figure 20. North America Acute Pancreatitis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 21. North America Acute Pancreatitis Market Share by Type (2016-2027)
Figure 22. North America Acute Pancreatitis Market Share by Application (2016-2027)
Figure 23. North America Acute Pancreatitis Market Share by Country (2016-2027)
Figure 24. United States Acute Pancreatitis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Canada Acute Pancreatitis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Acute Pancreatitis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Acute Pancreatitis Market Share by Type (2016-2027)
Figure 28. Europe Acute Pancreatitis Market Share by Application (2016-2027)
Figure 29. Europe Acute Pancreatitis Market Share by Country (2016-2027)
Figure 30. Germany Acute Pancreatitis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. France Acute Pancreatitis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. U.K. Acute Pancreatitis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Italy Acute Pancreatitis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Russia Acute Pancreatitis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Nordic Acute Pancreatitis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Acute Pancreatitis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Acute Pancreatitis Market Share by Type (2016-2027)
Figure 38. Asia-Pacific Acute Pancreatitis Market Share by Application (2016-2027)
Figure 39. Asia-Pacific Acute Pancreatitis Market Share by Region (2016-2027)
Figure 40. China Acute Pancreatitis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Japan Acute Pancreatitis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. South Korea Acute Pancreatitis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Southeast Asia Acute Pancreatitis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. India Acute Pancreatitis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Australia Acute Pancreatitis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Acute Pancreatitis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Acute Pancreatitis Market Share by Type (2016-2027)
Figure 48. Latin America Acute Pancreatitis Market Share by Application (2016-2027)
Figure 49. Latin America Acute Pancreatitis Market Share by Country (2016-2027)
Figure 50. Mexico Acute Pancreatitis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Brazil Acute Pancreatitis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Acute Pancreatitis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Acute Pancreatitis Market Share by Type (2016-2027)
Figure 54. Middle East & Africa Acute Pancreatitis Market Share by Application (2016-2027)
Figure 55. Middle East & Africa Acute Pancreatitis Market Share by Country (2016-2027)
Figure 56. Turkey Acute Pancreatitis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Saudi Arabia Acute Pancreatitis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. UAE Acute Pancreatitis Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Abbott Laboratories Revenue Growth Rate in Acute Pancreatitis Business (2016-2021)
Figure 60. McNeil Consumer Healthcare Revenue Growth Rate in Acute Pancreatitis Business (2016-2021)
Figure 61. Sun BioPharma Revenue Growth Rate in Acute Pancreatitis Business (2016-2021)
Figure 62. Atox Bio Revenue Growth Rate in Acute Pancreatitis Business (2016-2021)
Figure 63. Calcimedica Revenue Growth Rate in Acute Pancreatitis Business (2016-2021)
Figure 64. D-Pharm Ltd Revenue Growth Rate in Acute Pancreatitis Business (2016-2021)
Figure 65. Dynavax Technologies Revenue Growth Rate in Acute Pancreatitis Business (2016-2021)
Figure 66. Glaxosmithkline Revenue Growth Rate in Acute Pancreatitis Business (2016-2021)
Figure 67. Bottom-up and Top-down Approaches for This Report
Figure 68. Data Triangulation
Figure 69. Key Executives Interviewed
世界の急性膵炎市場 2021：企業別、地域別、種類・用途別 The Acute Pancreatitis market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations,…- 世界の慢性膵炎疼痛市場規模・現状・予測（2021年-2027年） Chronic pancreatitis is a long term inflammation of pancreas which leads to permanent damage and digestion capability of pancreas. Most common symptoms include severe abdominal pain, diabetes, weight loss, producing greasy and foul-smelling stools etc. Common cause associated with chronic pancreatit…
- 世界の急性間欠性ポルフィリン症（AIP）治療市場規模・現状・予測（2021年-2027年） Acute intermittent porphyria (AIP), also called Swedish porphyria, pyrroloporphyria, intermittent acute porphyria) is a rare autosomal dominant metabolic disorder affecting the production of heme resulting from a deficiency of the porphobilinogen deaminase. It is the most common of the acute porphyr…
- 世界の急性骨髄性白血病（AML）治療市場規模・現状・予測（2021年-2027年） Acute myeloid leukemia is the second frequent type (after acute lymphocytic leukemia) of leukemia diagnosed in infants. About 15% of children from birth to 19 years of age diagnosed with leukemia have acute myeloid leukemia. The risk of acute myeloid leukemia is closely associated with age. About 90…
- 世界の急性間欠性ポルフィリン症（AIP）治療市場規模・現状・予測（2021年-2027年） Acute intermittent porphyria (AIP), also called Swedish porphyria, pyrroloporphyria, intermittent acute porphyria) is a rare autosomal dominant metabolic disorder affecting the production of heme resulting from a deficiency of the porphobilinogen deaminase. It is the most common of the acute porphyr…